Now showing items 1-2 of 2

    • Measuring impacts of value to patients is crucial when evaluating palliative care 

      McCaffrey, Nicola; Currow, David Christopher; Eckermann, Simon Douglas (Elsevier, 2009-06)
      The inclusion of preparation for death and managing affairs in the end-of-life instrument designed by Borreani et al.1 to elicit preferences about dying is commendable. Of note, few quality-of-life (QOL) measurement tools ...
    • Modeling the cost-effectiveness of strategies for treating esophageal adenocarcinoma and high-grade dysplasia 

      Gordon, Louisa G; Hirst, Nicholas G; Mayne, George C; Watson, David Ian; Bright, Tim Flaxman; Cai, Wang; Barbour, Andrew P; Smithers, B Mark; Whiteman, David C; Eckermann, Simon Douglas; Australian Cancer Study Clinical Follow-Up Study Group (Springer-Verlag, 2012-08)
      Objective: To synthesize cost and health outcomes for current treatment pathways for esophageal adenocarcinoma and high grade dysplasia, and model comparative net clinical and economic benefits of alternative management ...